The healthcare world is seeing a significant shift in blood sugar therapy with the emergence of GLP-1 skin applications. These systems offer a possibly more user-friendly alternative to subcutaneous administrations of GLP-1 receptor agonists, minimizing the need for daily needle pricks. The innovation releases the drug directly through the surface,